ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
액티버제(알테플라제) 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 복합 성장률(CAGR) 8%로 21억 4,020만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 급성 허혈성 뇌졸중 발생률 증가, 시장 성장을 가속하는 고령화, 알테플라제의 효율성 향상을 위한 지속적인 연구 개발, 고혈압, 신장 질환, 뇌졸중 및 기타 심혈관 질환의 유병률 증가, 적용 범위 확대, 지원 의료 조치, 새로운 제형 및 전달 방법의 개발로 인해 발생했습니다. 에 기인합니다. 예측 기간 동안 주요 동향으로는 혈전증 부작용에 대한 인식 증가, 정밀의료에 대한 접근, 맞춤의료에 대한 접근 증가, 병용요법, 신기술의 보급, 신흥 시장 확대, 새로운 적응증에 대한 연구 등이 있습니다.
급성 허혈성 뇌졸중 발생률 증가는 액티버제(알테플라제) 시장의 성장을 가속할 것으로 예측됩니다. 급성 허혈성 뇌졸중은 혈전으로 인해 뇌로 가는 혈류가 차단되어 산소와 영양이 부족해져 뇌 조직이 손상되거나 사망에 이르는 질환입니다. 급성 허혈성 뇌졸중의 발병률 증가는 고령화, 고혈압, 비만, 흡연, 식습관 장애, 만성질환의 불규칙한 식습관 등의 위험요인과 관련이 있습니다. 액티바제(알테플라제)는 혈전 용해 요법으로 혈전을 녹여 뇌로 가는 혈류를 회복시켜 뇌 손상을 최소화하는 치료법으로, CDC에 따르면 2022년 미국 내 심혈관 질환으로 인한 사망자 6명 중 1명이 뇌졸중으로 사망할 것으로 예상에 따라 뇌졸중의 결과를 관리하는 데 있어 액티바제와 같은 효과적인 치료법의 중요성이 강조되고 있습니다. 이러한 급성 허혈성 뇌졸중 발생률 증가가 액티버제(알테플라제) 시장을 견인하고 있습니다.
헬스케어 지출 증가는 액티버제(알테플라제) 시장의 성장을 가속할 것으로 예측됩니다. 인구 고령화, 의료 발전, 만성 질환의 유병률 증가, 의료 서비스에 대한 수요 증가 등의 요인이 의료비 지출 증가에 기여하고 있습니다. 혈전 용해제와 같은 혁신적인 치료법에 대한 자금 지원을 포함한 의료에 대한 투자는 뇌졸중 및 심근경색 치료에 대한 수요 증가를 뒷받침하고 있습니다. 영국의 경우, 2022-2023년 사이 헬스케어 지출이 5.6% 증가하여 2023년에는 총 3,176억 3,000만 달러(2,920억 파운드)에 달할 것으로 예측됩니다. 이러한 헬스케어 서비스에 대한 투자 확대는 액티버제(알테플라제)와 같은 중요한 치료제에 대한 수요를 뒷받침하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장 제품 특성
분자 유형
투여 경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스, 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 악티바제(액티라제) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 악티바제(액티라제) 시장 : 성장률 분석
세계의 악티바제(액티라제) 시장 실적 : 규모와 성장, 2019-2024년
세계의 악티바제(액티라제) 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 악티바제(액티라제) : 전체 잠재 시장 규모(TAM)
제7장 세계 시장 가격 분석과 예측
제8장 시장 세분화
세계의 악티바제(액티라제) 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
분말
용액
기타
세계의 악티바제(액티라제) 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
급성 허혈성 뇌졸중
급성 심근경색
급성 대규모 폐색전증
기타
세계의 악티바제(액티라제) 시장 : 유통별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
세계의 악티바제(액티라제) 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
클리닉
병원
기타
제9장 임상 적응증 세계 시장 역학
약제 부작용
임상 적응증 발증률과 유병률
제10장 지역별/국가별 분석
세계의 악티바제(액티라제) 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 악티바제(액티라제) 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 개요
악티바제(액티라제) 시장 : 경쟁 구도
악티바제(액티라제) 시장 : 기업 개요
F. Hoffmann-La Roche Ltd
Genentech Inc.
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장 잠재력이 높은 국가, 전략
악티바제(액티라제) 시장, 2029년 : 새로운 기회를 제공하는 국가
악티바제(액티라제) 시장, 2029년 : 새로운 기회를 제공하는 부문
악티바제(액티라제) 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
LSH
영문 목차
영문목차
Activase (alteplase) is a recombinant tissue plasminogen activator (rt-PA) that serves as a thrombolytic (clot-busting) agent. It works by breaking down blood clots that obstruct blood flow, thereby aiding in the restoration of circulation and reducing tissue damage.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The activase (alteplase) market is primarily segmented into powder, solution, and other product forms. Its applications include treating acute ischemic stroke, acute myocardial infarction, acute massive pulmonary embolism, among others. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies. End-users of Activase include clinics, hospitals, and other healthcare settings.
The activase (alteplase)market research report is one of a series of new reports from The Business Research Company that provides activase (alteplase)market statistics, including activase (alteplase)industry global market size, regional shares, competitors with an activase (alteplase) market share, detailed activase (alteplase)market segments, market trends, and opportunities, and any further data you may need to thrive in the activase (alteplase)industry. This activase (alteplase)market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The activase (alteplase) market size is expected to see strong growth in the next few years. It will grow to $2,140.2 million in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to increasing incidence of acute ischemic stroke, aging population to propel market growth, continuous research and development to improve alteplase's efficiency, rise in the prevalence of hypertension, kidney diseases, strokes, and other cardiovascular diseases, extended application range, supportive healthcare policies, development of new formulations and delivery methods. Major trends in the forecast period include rising awareness about adverse effects of thrombosis, precision medicine approach, rising personalized medicine approaches, combination therapies, new technology penetration, expansion in emerging markets, research on new indications.
The increasing incidence of acute ischemic stroke is expected to drive the growth of the activase (alteplase) market. Acute ischemic stroke occurs when a blood clot blocks blood flow to the brain, causing a lack of oxygen and nutrients that can lead to brain damage or death of brain tissue. The rising incidence of acute ischemic stroke is linked to risk factors such as an aging population, hypertension, obesity, smoking, poor diet, and chronic disease mismanagement. Activase (alteplase) is a thrombolytic treatment that helps dissolve the blood clot, restoring blood flow to the brain and minimizing brain damage. According to the CDC, in 2022, strokes accounted for 1 in 6 deaths from cardiovascular diseases in the U.S., underscoring the importance of effective treatments like activase in managing stroke outcomes. This growing incidence of acute ischemic stroke is propelling the market for activase (alteplase).
The rise in healthcare spending is expected to drive the growth of the activase (alteplase) market. Factors like an aging population, medical advancements, the rising prevalence of chronic diseases, and increased demand for healthcare services contribute to rising healthcare expenditures. These investments in healthcare, including funding for innovative treatments like thrombolytics, support the growing need for treatments for stroke and myocardial infarction. In the UK, healthcare spending increased by 5.6% between 2022 and 2023, with total expenditure reaching $317.63 billion (£292 billion) in 2023. This growing investment in healthcare services supports the demand for critical treatments such as activase (alteplase).
The rising incidence of hypertension is driving the growth of the Activase (alteplase) market. Hypertension is a major risk factor for stroke and myocardial infarction, and its increasing prevalence-rising to 47.7% from 2021 to 2023, as reported by the CDC-contributes to higher stroke rates, further driving the demand for thrombolytic treatments like Activase. As hypertension remains a leading cause of cardiovascular events, the growing number of patients requiring stroke interventions boosts the market for Activase (alteplase).
Major players operating in the activase (alteplase) market are F. Hoffmann-La Roche Ltd.; Genentech Inc.
North America was the largest region in the activase (alteplase) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in activase (alteplase) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the activase (alteplase) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The activase (alteplase) market consists of sales of activase 2 mg (cathflo activase), activase 50 mg, and activase 100 mg. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Activase (Alteplase) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on activase (alteplase) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for activase (alteplase) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The activase (alteplase) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Powder; Solution; Other Products
2) By Application: Acute Ischemic Stroke; Acute Myocardial Infarction; Acute Massive Pulmonary Embolism; Other Applications
3) By Distribution: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
4) By End-User: Clinic; Hospital; Other End Users
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Genentech Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Activase (Alteplase) Market Characteristics
3. Activase (Alteplase) Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Activase (Alteplase) Market Trends And Strategies
5. Activase (Alteplase) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Activase (Alteplase) Growth Analysis And Strategic Analysis Framework
6.1. Global Activase (Alteplase) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Activase (Alteplase) Market Growth Rate Analysis
6.4. Global Activase (Alteplase) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Activase (Alteplase) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Activase (Alteplase) Total Addressable Market (TAM)
7. Global Activase (Alteplase) Market Pricing Analysis & Forecasts
8. Activase (Alteplase) Market Segmentation
8.1. Global Activase (Alteplase) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Powder
Solution
Other Products
8.2. Global Activase (Alteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Ischemic Stroke
Acute Myocardial Infarction
Acute Massive Pulmonary Embolism
Other Applications
8.3. Global Activase (Alteplase) Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
8.4. Global Activase (Alteplase) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinic
Hospital
Other End Users
9. Global Activase (Alteplase) Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Activase (Alteplase) Market Regional And Country Analysis
10.1. Global Activase (Alteplase) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Activase (Alteplase) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
